Facile analysis of protein-protein interactions in living cells by enriched visualization of the p-body

  • Choi, Miri (Anticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology) ;
  • Baek, Jiyeon (Anticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology) ;
  • Han, Sang-Bae (College of Pharmacy, Chungbuk National University) ;
  • Cho, Sungchan (Anticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology)
  • Received : 2018.03.09
  • Accepted : 2018.05.25
  • Published : 2018.10.31


Protein-Protein Interactions (PPIs) play essential roles in diverse biological processes and their misregulations are associated with a wide range of diseases. Especially, the growing attention to PPIs as a new class of therapeutic target is increasing the need for an efficient method of cell-based PPI analysis. Thus, we newly developed a robust PPI assay (SeePPI) based on the co-translocation of interacting proteins to the discrete subcellular compartment 'processing body' (p-body) inside living cells, enabling a facile analysis of PPI by the enriched fluorescent signal. The feasibility and strength of SeePPI (${\underline{S}}ignal$ ${\underline{e}}nhancement$ ${\underline{e}}xclusively$ on ${\underline{P}}-body$ for ${\underline{P}}rotein-protein$ ${\underline{I}}nteraction$) assay was firmly demonstrated with FKBP12/FRB interaction induced by rapamycin within seconds in real-time analysis of living cells, indicating its recapitulation of physiological PPI dynamics. In addition, we applied p53/MDM2 interaction and its dissociation by Nutlin-3 to SeePPI assay and further confirmed that SeePPI was quantitative and well reflected the endogenous PPI. Our SeePPI assay will provide another useful tool to achieve an efficient analysis of PPIs and their modulators in cells.


P-body;PPI modulator;Protein-Protein interaction;Translocation-based PPI assay


Supported by : ministry of Health & Welfare, National Research Foundation of Korea, KRIBB


  1. Zheng D, Ezzeddine N, Chen CY, Zhu W, He X and Shyu AB (2008) Deadenylation is prerequisite for P-body formation and mRNA decay in mammalian cells. J Cell Biol 182, 89-101
  2. Franks TM and Lykke-Andersen J (2008) The control of mRNA decapping and P-body formation. Mol Cell 32, 605-615
  3. DeRose R, Miyamoto T and Inoue T (2013) Manipulating signaling at will: chemically-inducible dimerization (CID) techniques resolve problems in cell biology. Pflugers Arch 465, 409-417
  4. Robida AM and Kerppola TK (2009) Bimolecular fluorescence complementation analysis of inducible protein interactions: effects of factors affecting protein folding on fluorescent protein fragment association. J Mol Biol 394, 391-409
  5. Iwakuma T and Lozano G (2003) MDM2, an introduction. Mol Cancer Res 1, 993-1000
  6. Shangary S and Wang S (2008) Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res 14, 5318-5324
  7. Burgess A, Chia KM, Haupt S, Thomas D, Haupt Y and Lim E (2016) Clinical Overview of MDM2/X-Targeted Therapies. Front Oncol 6, 7
  8. Kulikov R, Winter M and Blattner C (2006) Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation. J Biol Chem 281, 28575-28583
  9. Fry DC, Wartchow C, Graves B et al (2013) Deconstruction of a nutlin: dissecting the binding determinants of a potent protein-protein interaction inhibitor. ACS Med Chem Lett 4, 660-665
  10. Jung S, Choi M, Choi K et al (2017) Inactivation of human DGAT2 by oxidative stress on cysteine residues. PLoS One 12, e0181076
  11. Scott DE, Bayly AR, Abell C and Skidmore J (2016) Small molecules, big targets: drug discovery faces the protein-protein interaction challenge. Nat Rev Drug Discov 15, 533-550
  12. Jares-Erijman EA and Jovin TM (2003) FRET imaging. Nat Biotechnol 21, 1387-1395
  13. Kerppola TK (2008) Bimolecular fluorescence complementation (BiFC) analysis as a probe of protein interactions in living cells. Annu Rev Biophys 37, 465-487
  14. Lee KB, Hwang JM, Choi IS et al (2011) Direct monitoring of the inhibition of protein-protein interactions in cells by translocation of PKCdelta fusion proteins. Angew Chem Int Ed Engl 50, 1314-1317
  15. Lee KH, Lee S, Lee WY, Yang HW and Heo WD (2010) Visualizing dynamic interaction between calmodulin and calmodulin-related kinases via a monitoring method in live mammalian cells. Proc Natl Acad Sci U S A 107, 3412-3417
  16. Lee S, Ha JS, Lee SG and Kim TK (2012) Inducible biosynthetic nanoscaffolds as recruitment platforms for detecting molecular target interactions inside living cells. J Am Chem Soc 134, 11346-11349
  17. Aizer A, Brody Y, Ler LW, Sonenberg N, Singer RH and Shav-Tal Y (2008) The dynamics of mammalian P body transport, assembly, and disassembly in vivo. Mol Biol Cell 19, 4154-4166
  18. Kedersha N, Stoecklin G, Ayodele M et al (2005) Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 169, 871-884
  19. Marchi S, Patergnani S and Pinton P (2014) The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. Biochim Biophys Acta 1837, 461-469
  20. Smith JJ and Aitchison JD (2013) Peroxisomes take shape. Nat Rev Mol Cell Biol 14, 803-817
  21. Fletcher S and Hamilton AD (2007) Protein-protein interaction inhibitors: small molecules from screening techniques. Curr Top Med Chem 7, 922-927
  22. Gonzalez MW and Kann MG (2012) Chapter 4: Protein interactions and disease. PLoS Comput Biol 8, e1002819
  23. Wells JA and McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001-1009

Cited by

  1. Splicing Modifier Rescues the Disease Phenotypes in an In Vitro Human Spinal Muscular Atrophy Model pp.1557-8534, 2019,